Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Elite Laboratories, Inc. with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Shortage of an active ingredient
Shortage details
- Status
- Current
- Company
- Elite Laboratories, Inc.
- Package NDC
- 64850-551-01
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)
- Initial Posting
- Jul 14, 2023
Reason
Shortage of an active ingredient